Bezuclastinib (CGT9486) is an orally active, highly selective tyrosine kinase inhibitor with potent activity against KIT D816V. Bezuclastinib can be used for the research of nonadvanced systemic mastocytosis (NonAdvSM)[1].
Molecular Weight:
331.37
Purity:
98.59
CAS Number:
[1616385-51-3]
Formula:
C19H17N5O
Target:
c-Kit
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted